TradingView’s own chart and price feed. The page’s numbers are end-of-day closes.
Data provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.
The numbers
fiscal 2025, as filed with the SEC · 66-metric EOD snapshot via Databento
Market cap$739M
Enterprise value$712.5M
Revenue$18.7M −29.3%
True FCF (ex-SBC)$-52.8M +10.9%
Rule of 40-227.6%
ROIC-28.0%
True FCF Yield-7.2%
EPS, diluted$-0.57 +6.6%
Modern Valuation (EOD)
Market Cap$739M
Enterprise Value$712.5M
EV / True FCF—
EV / FCF—
EV / Gross Profit—
EV / EBIT—
EV / Sales38.17
P / E (GAAP)—
P / FCF—
P / Oper. CF—
P / Book2.77
Owner & Cash Yields
True FCF Yield-7.2%
FCF Yield-5.0%
Owner Earn. Yield-8.0%
Earnings Yield-8.8%
Shareholder Yield—
Buyback Yield—
Dividend Yield49.70%
Dividend / sh$2.50
Payout Ratio—
FCF / sh$-0.25
EPS (diluted)$-0.57
Compounder & Returns
Rule of 40-227.6%
ROIC-28.0%
Cash ROIC (CROIC)-15.4%
GP / Assets—
ROE-24.3%
ROA-21.5%
Gross Margin—
Oper. Margin-369.5%
Net Margin-347.0%
FCF Margin-198.3%
True FCF Margin-283.1%
Quality & Dilution
Cash Conversion—
Accrual Ratio−9.4%
SBC % of FCF—
SBC % of Rev84.8%
Reinvest. Rate—
Sales Growth Y/Y−29.3%
Sales 3Y CAGR−31.9%
EPS Growth Y/Y+6.6%
FCF Growth Y/Y+10.9%
FCF 3Y CAGR—
Share Change Y/Y+11.0%
Balance Sheet & Scale
Revenue (FY)$18.7M
Gross Profit (FY)—
Oper. Income (FY)$-69.0M
GAAP Net Income$-64.8M
True FCF (ex-SBC)$-52.8M
Cash & Equiv$26.1M
Total Debt—
Net Cash (Debt)$26.1M
Net Cash % MCap+3.5%
Debt / FCF (yrs)—
Current Ratio4.02145.86M sh
Price & Technicals (EOD)
Perf Week+1.62%
Perf Month+2.34%
Perf Quarter+16.17%
Perf Half Y+97.25%
Perf YTD+256.74%
SMA 20 Dist+0.06%$5.03
SMA 50 Dist+4.51%$4.81
SMA 100 Dist+27.32%$3.95
Window High−5.09%$5.30
Window Low+259.29%$1.40
RSI (14) · Vol52.856%v
Income Distribution & Cash Flow ConversionHow every dollar of OABI revenue flows through cost of goods, operating expenses, taxes, GAAP net income, and dilution-adjusted free cash flow
Standard Free Cash Flow (FCF)$-37.0M(-198.3% margin)
Less: Stock-Based Comp (SBC)−$15.8M
True FCF (Owner Cash ex-SBC)$-52.8M(-283.1% of rev)
Revenue by fiscal year
$34.7MFY21
$59.1MFY22
$34.2MFY23
$26.4MFY24
$18.7MFY25
Operating leverage — margins
GrossOperatingNet
Unlocked SEC EDGAR Accounting Statements (USD)All 3 statements · Common-size (% of Revenue / Assets) · YoY growth · Tap any core row to explain
Line Item (USD)
FY2021
FY2022
FY2023
FY2024
FY2025
YoY Δ
4Y CAGR
Trend
Income Statement
Revenue ▸
$34.7M
$59.1M
$34.2M
$26.4M
$18.7M
−29.3%
−14.4%
Research & Development (R&D)
$39.2M
$48.4M
$56.5M
$55.1M
$47.8M
−13.3%
+5.0%
Total Operating Expenses
$70.4M
$85.7M
$103.6M
$100.9M
$87.6M
−13.1%
+5.6%
Operating Income (EBIT) ▸
$-35.6M
$-26.6M
$-69.4M
$-74.5M
$-69.0M
+7.4%
—
Interest Expense
$7,000
$0
—
—
$0
—
—
Income Tax Expense
$-7.3M
$-3.7M
$-13.7M
$-9.4M
$-1.5M
+83.8%
—
GAAP Net Income ▸
$-27.0M
$-22.3M
$-50.6M
$-62.0M
$-64.8M
−4.4%
—
Diluted EPS ▸
$-0.33
$-0.26
$-0.51
$-0.61
$-0.57
+6.6%
—
Diluted Shares
82.6M
85.3M
99.7M
102.4M
113.6M
+11.0%
+8.3%
Balance Sheet
Cash & Equivalents
$0
$33.8M
$16.9M
$28.2M
$26.1M
−7.4%
—
Inventory
$1.1M
$1.1M
$1.1M
$48,000
$823,000
+1614.6%
−6.4%
Total Current Assets
$22.5M
$125.0M
$94.9M
$68.1M
$65.3M
−4.1%
+30.5%
Total Assets
$304.5M
$421.2M
$375.2M
$325.6M
$300.9M
−7.6%
−0.3%
Total Current Liabilities
$20.6M
$26.0M
$23.1M
$15.1M
$16.3M
+7.7%
−5.7%
Total Liabilities
$70.2M
$79.8M
$60.6M
$37.9M
$33.9M
−10.7%
−16.6%
Stockholders' Equity
$234.3M
$341.4M
$314.6M
$287.6M
$267.0M
−7.2%
+3.3%
Net Cash / (Net Debt)
$0
$33.8M
$16.9M
$28.2M
$26.1M
−7.4%
—
Invested Capital
$234.3M
$307.5M
$297.7M
$259.5M
$240.9M
−7.1%
+0.7%
Cash Flow & Capital Allocation
Operating Cash Flow (OCF) ▸
$-5.7M
$-3.6M
$2.3M
$-39.7M
$-36.5M
+8.1%
—
Depreciation & Amortization (D&A)
$16.3M
$18.2M
$19.5M
$23.6M
$21.8M
−7.8%
+7.6%
Stock-Based Compensation (SBC)
$15.1M
$18.3M
$24.8M
$21.5M
$15.8M
−26.4%
+1.2%
Capital Expenditures (CapEx)
$4.1M
$17.2M
$1.6M
$1.9M
$565,000
−69.9%
−39.0%
Free Cash Flow (FCF) ▸
$-9.7M
$-20.8M
$703,000
$-41.5M
$-37.0M
+10.9%
—
True FCF (ex-SBC Owner Cash)
$-24.8M
$-39.1M
$-24.1M
$-63.0M
$-52.8M
+16.2%
—
Fundamentals, income distribution and multi-year statements from SEC EDGAR filings (public domain). Valuation multiples, performance and technicals computed from Databento 1D EOD closes. For information only, not investment advice.
On the Wire
what OABI did at the next close after each story
No Wire story has named OABI yet.
The Wire at 7 AM ET, free. Top stories with a bull and a bear case on each, every morning. No account needed.
What happened · big days
29 big days in a year, and what we hold on each
A big day is a close more than 6.44% from the one before, three times OABI’s median day (2.15%). On 2 of the 29, its peer group moved the same way at least half as far. We show what we hold. We never name a cause.
every other trading daya big day, numbered in the list below±6.44%Hover a bar for its day. Click a big day to open it.
Shaded: since our stories began, Jun 10. Tap a bar for its day.
#DayOABIWhat we hold that dayGroup (median of 4) · each
1 Nov 25, 2025+7.51%
Before our storiesgroup +0.5%, did not move with it
1Nov 25, 2025+7.51%
Before our stories
+0.5% did not move with itCRL +4.5 · IQV +1.6 · INCY −0.7 · MEDP −1.1
2 Dec 3, 2025+9.94%
Before our storiesgroup +0.4%, did not move with it
2Dec 3, 2025+9.94%
Before our stories
+0.4% did not move with itCRL +5.7 · IQV +0.7 · INCY +0.1 · MEDP −1.2
3 Dec 11, 2025+8.00%
Before our storiesgroup +1.0%, did not move with it
3Dec 11, 2025+8.00%
Before our stories
+1.0% did not move with itIQV +1.4 · INCY +1.0 · MEDP +1.0 · CRL −0.2
4 Mar 5, 2026+10.50%
Resultsgroup +0.6%, did not move with it
4Mar 5, 2026+10.50%
ResultsFirst close after the Mar 4 results filing
+0.6% did not move with itCRL +1.0 · MEDP +0.8 · IQV +0.3 · INCY −1.6
5 May 8, 2026+12.93%
Resultsgroup −0.5%, did not move with it
5May 8, 2026+12.93%
ResultsFirst close after the May 7 results filing
−0.5% did not move with itINCY +0.8 · IQV +0.0 · MEDP −1.1 · CRL −2.2
6 May 12, 2026+10.78%
Before our storiesgroup +0.4%, did not move with it
6May 12, 2026+10.78%
Before our stories
+0.4% did not move with itIQV +0.9 · MEDP +0.6 · CRL +0.1 · INCY −1.2
7 May 13, 2026+8.65%
Before our storiesgroup −0.9%, did not move with it
7May 13, 2026+8.65%
Before our stories
−0.9% did not move with itMEDP +1.0 · INCY −0.3 · IQV −1.5 · CRL −3.5
8 May 14, 2026+8.96%
Before our storiesgroup −1.1%, did not move with it
8May 14, 2026+8.96%
Before our stories
−1.1% did not move with itIQV −1.0 · MEDP −1.1 · INCY −1.2 · CRL −2.3
9 May 20, 2026+8.86%
Before our storiesgroup +1.0%, did not move with it
9May 20, 2026+8.86%
Before our stories
+1.0% did not move with itCRL +2.4 · INCY +1.6 · MEDP +0.5 · IQV −1.0
10 Jun 5, 2026−6.77%
Before our storiesgroup −1.4%, did not move with it
10Jun 5, 2026−6.77%
Before our stories
−1.4% did not move with itCRL −2.4 · IQV −1.8 · MEDP −1.0 · INCY +1.1
11 Jun 8, 2026−8.06%
Before our storiesgroup +0.5%, did not move with it
11Jun 8, 2026−8.06%
Before our stories
+0.5% did not move with itINCY −1.7 · IQV +0.1 · MEDP +0.8 · CRL +2.8
12 Jun 15, 2026−7.05%
Nothing on OABIgroup −0.8%, did not move with it
12Jun 15, 2026−7.05%
Nothing on OABINo OABI story, brief or results filing in our record that day
−0.8% did not move with itINCY −6.0 · IQV −1.7 · MEDP +0.0 · CRL +0.5
13 Jun 18, 2026+15.27%
Nothing on OABIgroup −0.1%, did not move with it
13Jun 18, 2026+15.27%
Nothing on OABINo OABI story, brief or results filing in our record that day
−0.1% did not move with itCRL +1.5 · MEDP +0.7 · INCY −0.8 · IQV −1.7
14 Jun 25, 2026+10.09%
Nothing on OABIgroup +0.9%, did not move with it
14Jun 25, 2026+10.09%
Nothing on OABINo OABI story, brief or results filing in our record that day
+0.9% did not move with itCRL +5.3 · MEDP +1.4 · IQV +0.4 · INCY −0.9
15 Jul 13, 2026−7.86%
Nothing on OABIgroup −1.5%, did not move with it
15Jul 13, 2026−7.86%
Nothing on OABINo OABI story, brief or results filing in our record that day
−1.5% did not move with itINCY −2.1 · CRL −1.6 · MEDP −1.5 · IQV −0.1
16 Aug 6, 2026+10.34%
Nothing on OABIgroup −0.8%, did not move with it
16Aug 6, 2026+10.34%
Nothing on OABINo OABI story, brief or results filing in our record that day
−0.8% did not move with itCRL +1.8 · MEDP −0.5 · INCY −1.2 · IQV −1.5
17 Aug 7, 2026+37.50%
Resultsgroup +1.4%, did not move with it
17Aug 7, 2026+37.50%
ResultsFirst close after the Aug 6 results filing
+1.4% did not move with itIQV +2.7 · INCY +1.8 · MEDP +1.0 · CRL +0.8
18 Aug 10, 2026+10.06%
Nothing on OABIgroup +1.7%, did not move with it
18Aug 10, 2026+10.06%
Nothing on OABINo OABI story, brief or results filing in our record that day
+1.7% did not move with itCRL +3.6 · MEDP +2.0 · IQV +1.4 · INCY +0.8
19 Aug 17, 2026+13.02%
Nothing on OABIgroup +2.6%, did not move with it
19Aug 17, 2026+13.02%
Nothing on OABINo OABI story, brief or results filing in our record that day
+2.6% did not move with itMEDP +3.2 · INCY +2.8 · CRL +2.4 · IQV +1.9
20 Aug 19, 2026+6.89%
Nothing on OABIgroup +3.9%, moved with OABI
20Aug 19, 2026+6.89%
Nothing on OABINo OABI story, brief or results filing in our record that day
+3.9% moved with OABIINCY +4.0 · CRL +3.9 · IQV +3.9 · MEDP +3.0
21 Aug 24, 2026+8.78%
Nothing on OABIgroup +0.1%, did not move with it
21Aug 24, 2026+8.78%
Nothing on OABINo OABI story, brief or results filing in our record that day
+0.1% did not move with itCRL +1.1 · IQV +0.2 · INCY +0.1 · MEDP −0.1
22 Sep 2, 2026+13.51%
Nothing on OABIgroup +2.6%, did not move with it
22Sep 2, 2026+13.51%
Nothing on OABINo OABI story, brief or results filing in our record that day
+2.6% did not move with itCRL +3.3 · INCY +3.1 · IQV +2.1 · MEDP +1.7
23 Sep 4, 2026−8.84%
Nothing on OABIgroup −1.2%, did not move with it
23Sep 4, 2026−8.84%
Nothing on OABINo OABI story, brief or results filing in our record that day
−1.2% did not move with itCRL −1.6 · IQV −1.4 · INCY −1.0 · MEDP −0.3
24 Sep 14, 2026+10.07%
Nothing on OABIgroup +1.0%, did not move with it
24Sep 14, 2026+10.07%
Nothing on OABINo OABI story, brief or results filing in our record that day
+1.0% did not move with itIQV +1.5 · MEDP +1.3 · INCY +0.6 · CRL −1.9
25 Sep 22, 2026+7.42%
Nothing on OABIgroup +1.4%, did not move with it
25Sep 22, 2026+7.42%
Nothing on OABINo OABI story, brief or results filing in our record that day
+1.4% did not move with itCRL +2.2 · INCY +1.8 · MEDP +1.0 · IQV +0.1
26 Oct 6, 2026−11.59%
Nothing on OABIgroup −2.1%, did not move with it
26Oct 6, 2026−11.59%
Nothing on OABINo OABI story, brief or results filing in our record that day
−2.1% did not move with itMEDP −2.8 · IQV −2.3 · CRL −1.9 · INCY −1.2
27 Oct 27, 2026+7.59%
Nothing on OABIgroup 0.0%, did not move with it
27Oct 27, 2026+7.59%
Nothing on OABINo OABI story, brief or results filing in our record that day
0.0% did not move with itINCY +2.9 · CRL +0.4 · MEDP −0.4 · IQV −0.8
28 Oct 28, 2026+6.45%
Nothing on OABIgroup +2.8%, did not move with it
28Oct 28, 2026+6.45%
Nothing on OABINo OABI story, brief or results filing in our record that day
+2.8% did not move with itCRL +4.2 · MEDP +2.8 · IQV +2.8 · INCY +0.2
29 Nov 5, 2026−6.76%
Nothing on OABIgroup −3.6%, moved with OABI
29Nov 5, 2026−6.76%
Nothing on OABINo OABI story, brief or results filing in our record that day
−3.6% moved with OABICRL −4.1 · INCY −3.9 · MEDP −3.3 · IQV +0.4
A story on the same day is not a cause, and a group move is not proof either. Group: the median of IQV, INCY, MEDP and CRL that day, the largest companies in OABI’s SEC industry; “moved with OABI” means the same direction and at least half the size.
What’s next · results
Before the next report: what the first day after the last four did
Six trading days after each results filing (SEC 8-K, Item 2.02). Day 1 is the first close after each filing: the next day’s for a filing after the close, the same day’s otherwise. Each time, day 6 ended on the same side as day 1.
Reported Mar 4, 2026
day 1+10.50%day 6+2.21%
Reported May 7, 2026
day 1+12.93%day 6+48.30%
Reported Aug 6, 2026
day 1+37.50%day 6+50.89%
Reported Oct 30, 2026
day 1−2.29%day 6−3.82%
Next report: expected late JanuaryEstimated from the dates of its last four results filings. Not announced. Since the Oct 30 report: −2.87%. Four reports is a small sample.
Each line is OABI’s close against its close before the filing, on licensed end-of-day closes. What happened after each report, not a forecast; a move on the day is not a cause.
Same industry
OABI against four same-industry peers, a year at 100
OABI is up 2.9 times in a year. All four did less: Charles River Laboratories International (+98.8%), Incyte (+15.4%), IQVIA Holdings (+14.7%) and Medpace Holdings (+9.3%). Weekly closes, Nov 21, 2025 = 100, on a log scale so a threefold rise and a 9.3% rise both read honestly.
End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in OABI’s SEC industry (Services-Commercial Physical & Biological Research) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.